| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2500291 | Farmacia Hospitalaria | 2010 | 11 Pages |
Abstract
The BIA of a FC of atorvastatin and amlodipine shows that the use of this medication for approved indications could generate net savings for the SNS of â¬9.9M for the period 2009-2011.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
M. De Salas, J. Fernández De Bobadilla, B. Ferro, J. Rejas,